Evidence map›Paper›PMID 39532531›Full record

ArticleLife science alliance2025

Nef mediates neuroimmune response, myelin impairment, and neuronal injury in EcoHIV-infected mice.

Jessica K Schenck, Cheryl Clarkson-Paredes, Tatiana Pushkarsky, Yongsen Wang, Robert H Miller, Michael I Bukrinsky

Abstract read
In one paragraph

Article in Life science alliance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Targeting NAAG metabolism restores cognition and synaptic integrity in EcoHIV-infected mice.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Update on neurological complications of HIV.Current opinion in HIV and AIDS · 2025
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jessica K SchenckSchool of Medicine and Health Sciences, The George Washington University, Washington, DC, USA.ORCID 0000-0003-0229-0606
Cheryl Clarkson-ParedesSchool of Medicine and Health Sciences, The George Washington University, Washington, DC, USA.
Tatiana PushkarskySchool of Medicine and Health Sciences, The George Washington University, Washington, DC, USA.
Yongsen WangSchool of Medicine and Health Sciences, The George Washington University, Washington, DC, USA.
Robert H MillerSchool of Medicine and Health Sciences, The George Washington University, Washington, DC, USA.ORCID 0000-0001-9050-4154
Michael I BukrinskySchool of Medicine and Health Sciences, The George Washington University, Washington, DC, USA mbukrins@gwu.edu.ORCID 0000-0002-8593-0770

Funding

SWG 2: Cure Research Scientific Working GroupP30AI117970 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI Italo Mocchetti · 2015 to 2026
$29.6M
Supplement to R01 NS124477R01NS124477 · NINDS · GEORGE WASHINGTON UNIVERSITY · PI BUKRINSKY, MICHAEL ILYA, TYOR, WILLIAM R · 2021 to 2025
$3.6M
Phase II study to evaluate the efficacy and safety of baricitinib for reduction of HIV in the central nervous systemR01MH128158 · NIMH · EMORY UNIVERSITY · PI Christina Gavegnano, Vincent Charles Marconi · 2022 to 2026
$3.2M
Lipid raft therapy – a novel therapeutic approach for HIV-associated cardiometabolic co-morbiditiesR01HL158305 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI BUKRINSKY, MICHAEL ILYA, SVIRIDOV, DMITRI · 2021 to 2024
$2.6M
NHLBI NIH HHS R01 HL158305NIAID NIH HHS P30 AI117970NIMH NIH HHS R01 MH128158NINDS NIH HHS R01 NS124477
6 · The paper itself

Abstract

The introduction of antiretroviral therapy has markedly improved the management of HIV-associated neurocognitive disorders (HAND). However, HAND still affects nearly half of HIV-infected individuals, presenting significant challenges to their well-being. This highlights the critical need for a deeper understanding of HAND mechanisms. Among HIV viral proteins, Nef is notable for its multifaceted role in HIV pathogenesis, though its specific involvement in HAND remains unclear. To investigate this, we used a murine model infected with Nef-expressing (EcoHIV) and Nef-deficient (EcoHIVΔNef) murine HIV. Comparative analyses revealed increased neuroinflammation and reduced myelin and neuronal integrity in EcoHIV-infected brains compared with those with EcoHIVΔNef. Both viruses induced astrogliosis, with stronger GFAP activation in Nef-deficient infections. These findings suggest that Nef contributes to neuroinflammation, primarily through microglial targeting and demyelination, although other factors may regulate astrogliosis. Our results indicate that Nef may significantly contribute to neuronal injury in EcoHIV-infected mice, offering insights into Nef-induced neuropathology in HAND and guiding future research.

Indexed as

Disease Models, AnimalMyelin Sheathnef Gene Products, Human Immunodeficiency VirusNeuronsAIDS Dementia ComplexAnimalsAstrocytesBrainDemyelinating DiseasesFemaleGliosisHIV-1HIV InfectionsHumansMaleMicenef Gene Products, Human Immunodeficiency Virusnef protein, Human immunodeficiency virus 1

Identifiers

PMID39532531
PMCPMC11557684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.